3D Medicines Inc 2023 Sustainability Report
Company: 3D Medicines Inc
Sector: Manufacturing
Country: China
Year: 2023
Type: Sustainability Report
Pages: 34
The report describes the company's 2023 ESG governance, environmental management, workforce practices, and public-welfare activities. The Board of Directors is identified as the highest ESG decision-making body, while an ESG work team implements activities. Reported highlights include total GHG emissions of 412.85 tCO2e, 198 full-time employees, zero deaths due to work-related injuries, and donation-related expenses exceeding RMB 96 million. The report also details climate-risk responses, energy and water conservation measures, employee training, drug accessibility, and charitable drug donations.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.